Is a complete blood cell count useful in determining the prognosis of pulmonary embolism?

Wiener Klinische Wochenschrift

Volumn 126, Issue 11-12, 2014, Pages 347-354

  Sen, Hadice Selimoglu ^a   Abakay, Ozlem ^a   Tanrikulu, Abdullah Cetin ^a   Sezgi, Cengizhan ^a   Taylan, Mahsuk ^a   Abakay, Abdurrahman ^a   Kaya, Halide ^a   Senyigit, Abdurrahman ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Complete blood cell count; Prognostic factors; Pulmonary embolism; Red cell distribution width

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER; OXYGEN;

ACUTE DISEASE; ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD PRESSURE; CLINICAL LABORATORY; DEMOGRAPHY; FEMALE; HEMATOLOGICAL PARAMETERS; HOSPITAL PATIENT; HUMAN; KIDNEY FUNCTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; NEUTROPHIL LYMPHOCYTE RATIO; OXYGEN SATURATION; PLATELET DISTRIBUTION WIDTH; PROGNOSIS; RED CELL DISTRIBUTION; RETROSPECTIVE STUDY; SCORING SYSTEM; SIMPLIFIED PULMONARY EMBOLISM SEVERITY INDEX; THROMBOCYTE VOLUME; BLOOD; EPIDEMIOLOGY; METABOLISM; MIDDLE AGED; MORTALITY; PREVALENCE; PULMONARY EMBOLISM; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TURKEY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD CELL COUNT; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYGEN; PREVALENCE; PROGNOSIS; PULMONARY EMBOLISM; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TURKEY; YOUNG ADULT;

EID: 84903730592     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-014-0537-1     Document Type: Article

References (40)

1. Giuntini C, Di Ricco G, Marini C, Melillo E, Palla A. Pulmonary embolism: epidemiology. Chest. 1995;107:3-9.
2. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353:1386-9. (Pubitemid 29192409)
3. Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galie N, Pruszczyk P, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008;29:2276-315.
4. Kearon C, Kahn SR, Agnelli G, Goldhaber SZ, Raskob G, Comerota J. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:454-545.
5. Zee RY, Glynn RJ, Cheng S, Steiner L, Rose L, Ridker PM. An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism: the women's genome health study. Circ Cardiovasc Genet. 2009;2:57-62.
6. Fox EA, Kahn SR. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost. 2005;94:362-5. (Pubitemid 41122491)
7. Rhodes CJ, Wharton J, Howard LS, Gibbs JS, Wilkins MR. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart. 2011;97:1054-60.
8. Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the women's health initiative observational study. Arch Intern Med. 2005;165:500-8. (Pubitemid 40344380)
9. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, et al Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005;45:1638-43. (Pubitemid 40704499)
10. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138-50. (Pubitemid 36056721)
11. Onsrud M, Thorsby E. Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. Effect on natural killer cell activity. Scand J Immunol. 1981;13:573-9. (Pubitemid 11112499)
12. Cho KH, Jeong MH, Ahmed K, Hachinohe D, Choi HS, Chang SY, et al. Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2011;107:849-56.
13. Uthamalingam S, Patvardhan EA, Subramanian S, Ahmed W, Martin W, Daley M, et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol. 2011;107:433-8.
14. Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172:1041-6. (Pubitemid 41476544)
15. Jiménez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, et al RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170:1383-9.
16. World Health Organization. Nutritional anemia: report of a WHO Scientific Group. Geneva: World Health Organization; 1968.
17. Lapez-Jimanez L, Montero M, Gonzailez-Fajardo JA, Arcelus JI, Suairez C, Lobo JL, et al RIETE Investigators. Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE). Haematologica. 2006;91(8):1046-51. (Pubitemid 44204770)
18. Zahorec R. Ratio of neutrophil to lymphocyte counts - rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102:5-14.
19. Karnad A, Poskitt TR. The automated complete blood cell count. Use of the red blood cell volume distribution width and mean platelet volume in evaluating anemia and thrombocytopenia. Arch Intern Med. 1985;145:1270-2. (Pubitemid 15231915)
20. Thompson WG, Meola T, Lipkin M Jr, Freedman ML. Red cell distribution width, mean corpuscular volume, and transferrin saturation in the diagnosis of iron deficiency. Arch Intern Med. 1988;148:2128-30.
21. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007;50:40-7. (Pubitemid 46963527)
22. Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009;158:659-66.
23. Ozsu S, Abul Y, Gunaydin S, Orem A, Ozlu T. Prognostic value of red cell distribution width in patients with pulmonary embolism. Clin Appl Thromb Hemost. 2012. Epub ahead of print.
24. Zorlu A, Bektasoglu G, Guven FM, Dogan OT, Gucuk E, Ege MR, Altay H, Cinar Z, Tandogan I, Yilmaz MB. Usefulness of admission red cell distribution width as a predictor of early mortality in patients with acute pulmonary embolism. Am J Cardiol. 2012;109:128-34.
25. Donze J, Labarere J, Mean M, Jimenez D, Aujesky D. Prognostic importance of anaemia in patients with acute pulmonary embolism. Thromb Haemost. 2011;106:289-95.
26. Jagroop IA, Mikhailidis DP. Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer. Platelets. 2001;12:171. (Pubitemid 32299586)
27. Samara WM, Gurbel PA. The role of platelet receptors and adhesion molecules in coronary artery disease. Coron Artery Dis. 2003;14:65-79. (Pubitemid 36337819)
28. Kostrubiec M, Labyk A, Pedowska-Wloszek J, Hrynkiewicz-Szymanska A, Pacho S, Jankowski K, et al. Mean platelet volume predicts early death in acute pulmonary embolism. Heart. 2010;96:460-5.
29. Braekkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J, Hansen JB. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø study. J Thromb Haemost. 2010;8:157-62.
30. Righini M, Roy PM, Meyer G, Verschuren F, Aujesky D, Le Gal G. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. J Thromb Haemost. 2011;9:2115-7.
31. Laporte S, Mismetti P, De'cousus H, Uresandi F, Otero R, Lobo JL, et al RIETE Investigators. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) registry. Circulation. 2008;117:1711-6. (Pubitemid 351482603)
32. Nijkeuter M, Sohne M, Tick LW, Kamphuisen PW, Kramer MH, Laterveer L, et al Christopher Study Investigators. The natural course of hemodynamically stable pulmonary embolism: clinical outcome and risk factors in a large prospective cohort study. Chest. 2007;131:517-23. (Pubitemid 46280414)
33. Shantikumar S, Grant PJ, Catto AJ, Bamford JM, Carter AM. Elevated C-reactive protein and long-term mortality after ischaemic stroke: relationship with markers of endothelial cell and platelet activation. Stroke. 2009;40:977-9.
34. Boekholdt SM, Hack CE, Sandhu MS, Luben R, Bingham SA, Wareham NJ, et al. C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003. Atherosclerosis. 2006;187:415-22. (Pubitemid 43963024)
35. Marchena Yglesias PJ, Nieto Rodríguez JA, Serrano Martínez S, Belinchón Moya O, Cortés Carmona A, Díaz de Tuesta A, et al. Acute-phase reactants and markers of inflammation in venous thromboembolic disease: correlation with clinical and evolution parameters. An Med Interna. 2006;23:105-10.
36. Hogg K, Hinchliffe E, Haslam S, Sethi B, Carrier M, Lecky F. Predicting short term mortality after investigation for venous thromboembolism. Thromb Res. 2013;131:141-6.
37. Abul Y, Karakurt S, Ozben B, Toprak A, Celikel T. C-reactive protein in acute pulmonary embolism. J Investig Med. 2011;59:8-14.
38. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet. 1960;1:1309-12.
39. Konstantinides S. Thrombolysis in submassive pulmonary embolism? Yes. J Thromb Haemost. 2003;1:1127-9.
40. Dalen JE. Thrombolysis in submassive pulmonary embolism? No. J Thromb Haemost. 2003;1:1130-2.